Qrons Inc. financial data

Symbol
QRON on OTC
Location
28 10 Jackson Avenue, #26 N, Long Island City, New York
State of incorporation
Wyoming
Fiscal year end
December 31
Former names
BIOLABMART INC. (to 7/18/2017)
Latest financial report
10-Q - Q2 2024 - Aug 16, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 0.44 % 0%
Debt-to-equity -100 % +0.03%
Return On Equity 61.4 % +27.1%
Return On Assets -15K % -36.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 13.9M shares +2.65%
Common Stock, Shares, Outstanding 13.9M shares +2.65%
Entity Public Float 1.33M USD 0%
Common Stock, Value, Issued 1.4K USD +2.65%
Weighted Average Number of Shares Outstanding, Diluted 20.5M shares +9.31%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 0 USD
Research and Development Expense 580K USD +233%
General and Administrative Expense 113K USD -69%
Operating Income (Loss) -749K USD -25.8%
Nonoperating Income (Expense) -104K USD +60.9%
Net Income (Loss) Attributable to Parent -860K USD -38.2%
Earnings Per Share, Basic -0.01 USD/shares
Earnings Per Share, Diluted 0 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 3.64K USD -19%
Assets, Current 11.7K USD +76.2%
Assets 11.7K USD +76.2%
Liabilities, Current 1.12M USD -15%
Liabilities 1.24M USD -5.68%
Retained Earnings (Accumulated Deficit) -10.5M USD -8.94%
Stockholders' Equity Attributable to Parent -1.23M USD +6.09%
Liabilities and Equity 11.7K USD +76.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -19.3K USD -42%
Net Cash Provided by (Used in) Financing Activities 22.5K USD +50%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 13.9M shares +2.65%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 11.7K USD +76.2%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD
Preferred Stock, Shares Issued 2K shares 0%
Preferred Stock, Shares Authorized 10K shares 0%
Additional Paid in Capital 9.25M USD +11.3%
Preferred Stock, Shares Outstanding 2K shares 0%
Interest Expense 57K USD -62%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%